Pharma Journalist -

Maze Therapeutics, a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal,…
Read More...

Novartis announced that it has entered into a global license and collaboration agreement with PTC Therapeutics for PTC518, an HTT mRNA splice modulator with the potential to become the…
Read More...

Johnson & Johnson announced the submission of two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA) seeking approval of TREMFYA…
Read More...

Valneva SE, a specialty vaccine company, announced that it has submitted a label extension application to the U.S. Food and Drug Administration (FDA) to potentially extend the use of…
Read More...

Acadia Pharmaceuticals Inc. announced it has entered into an exclusive worldwide license agreement with Saniona for the development and commercialization of SAN711, a first-in-class,…
Read More...

Roche announced today that it has entered into a definitive merger agreement to acquire Poseida Therapeutics, Inc., a public clinical-stage biopharmaceutical company pioneering…
Read More...

Sarepta Therapeutics, Inc. announced an exclusive global licensing and collaboration agreement with Arrowhead Pharmaceuticals, Inc. Sarepta will obtain exclusive global rights to…
Read More...

Adragos Pharma, a global pharmaceutical contract development and manufacturing organization (CDMO) headquartered in Munich, Germany, has acquired Baccinex, a Swiss-based expert in…
Read More...

Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Company’s supplemental New…
Read More...

Eton Pharmaceuticals, Inc. an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, announced that it has acquired the U.S. rights to…
Read More...